Grant: Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
University of Toronto
$4,950.00
The role of FHL2 in matrix stiffness-mediated mesenchymal stem cell osteogenic differentiation
FY 2012-13
Summary
Musculoskeletal diseases are among the most significant economic and health burdens in Canada. A promising approach to repair or replace diseased or damaged tissue is to use adult mesenchymal stem cells (MSCs) delivered to the repair site with a biomaterial. However, for MSC-based therapies to realize their full potential, biomaterials that predictably guide MSC function to restore tissue function are needed. Interestingly, a biomaterial's mechanical stiffness has profound impact on the ability of the MSCs to mature to functional cells, like those that make bone. If we can understand and harness this phenomenon, we should be able to design better biomaterials for the regeneration of bone and other tissues.
Based on preliminary work in our lab, we hypothesize that a molecule called FHL2 is required for a biomaterial's stiffness to direct bone formation by MSCs. In this summer research project, an undergraduate researcher will test this hypothesis. Using genetics and drugs, she will manipulate FHL2 levels in human and mouse MSCs grown in the lab and then test whether they can become bone cells on biomaterials with different mechanical stiffnesses. We expect that FHL2 will be required for MSCs to become bone cells on different biomaterials. These studies will provide significant new insights into the molecular mechanisms that link biomaterial design to MSC-based tissue regeneration. Longer term, this work is expected to lead to novel strategies to regenerate bone by modulating FHL2 activity using drugs or customized biomaterials.
More immediately, this project will introduce a promising young scientist to research in regenerative medicine and musculoskeletal health and train her in an interdisciplinary research environment with a track record of success in training new scientists. By equipping and encouraging her to pursue this field, our goal is that she will contribute to advances in health technology in the future to improve the health of Canadians.
Department
Program
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
278048
Name
Ngai Jessica
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Undergraduate: Mobility, musculoskeletal health & arthritis - IMHA
Projecttitle
The role of FHL2 in matrix stiffness-mediated mesenchymal stem cell osteogenic differentiation
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$4,950
Cihrequipment2
$0
Programname2
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Keyworddelim
Biomaterials; Biomechanics; Bone; Stem Cells; Tissue Engineering
Abstract
Musculoskeletal diseases are among the most significant economic and health burdens in Canada. A promising approach to repair or replace diseased or damaged tissue is to use adult mesenchymal stem cells (MSCs) delivered to the repair site with a biomaterial. However, for MSC-based therapies to realize their full potential, biomaterials that predictably guide MSC function to restore tissue function are needed. Interestingly, a biomaterial's mechanical stiffness has profound impact on the ability of the MSCs to mature to functional cells, like those that make bone. If we can understand and harness this phenomenon, we should be able to design better biomaterials for the regeneration of bone and other tissues.
Based on preliminary work in our lab, we hypothesize that a molecule called FHL2 is required for a biomaterial's stiffness to direct bone formation by MSCs. In this summer research project, an undergraduate researcher will test this hypothesis. Using genetics and drugs, she will manipulate FHL2 levels in human and mouse MSCs grown in the lab and then test whether they can become bone cells on biomaterials with different mechanical stiffnesses. We expect that FHL2 will be required for MSCs to become bone cells on different biomaterials. These studies will provide significant new insights into the molecular mechanisms that link biomaterial design to MSC-based tissue regeneration. Longer term, this work is expected to lead to novel strategies to regenerate bone by modulating FHL2 activity using drugs or customized biomaterials.
More immediately, this project will introduce a promising young scientist to research in regenerative medicine and musculoskeletal health and train her in an interdisciplinary research environment with a track record of success in training new scientists. By equipping and encouraging her to pursue this field, our goal is that she will contribute to advances in health technology in the future to improve the health of Canadians.
Competitiondate
201301
Approvedterm2
0 yr 3 mths
Pinamesdelim
Ngai, Jessica
Approvedterm
0 an 3 mois
Cihrcontribution2
~ $4,950~ $0~